|
業務類別
|
Biotechnology |
|
業務概覽
|
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material. |
| 公司地址
| 555 Heritage Drive, Suite 200, Jupiter, FL, USA, 33458 |
| 電話號碼
| +1 858 550-7500 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.ligand.com |
| 員工數量
| 47 |
| Mr. Octavio Espinoza |
Chief Financial Officer and Principal Accounting Officer |
美元 469.55K |
27/02/2026 |
| Mr. Todd C. Davis |
Chief Executive Officer and Director |
美元 695.83K |
27/02/2026 |
| Mr. Andrew Reardon |
Chief Legal Officer and Secretary |
美元 451.95K |
22/04/2025 |
|
|
| Dr. John L. LaMattina, PhD |
Independent Director |
27/02/2026 |
| Dr. John W. Kozarich,PhD |
Chairman of the Board |
27/02/2026 |
| Mr. Todd C. Davis |
Chief Executive Officer and Director |
27/02/2026 |
| Mr. Jason M. Aryeh |
Independent Director |
27/02/2026 |
| Dr. Stephen L. Sabba,M.D. |
Independent Director |
27/02/2026 |
| Dr. Nancy Ryan Gray, PhD |
Independent Director |
27/02/2026 |
| Mr. Jason Haas |
Independent Director |
27/02/2026 |
| Ms. Martine Zimmermann, Pharm.D. |
Independent Director |
27/02/2026 |
|
|
|
|
